Automated Merging in a Cooperative Adaptive Cruise Control (CACC) System

Cooperative Adaptive Cruise Control (CACC) is a form of cruise control in which a vehicle maintains a constant headway to its preceding vehicle using radar and vehicle-to-vehicle (V2V) communication. Within the Connect & Drive1 project we have implemented and tested a prototype of such a system, with IEEE 802.11p as the enabling communication technology. In this paper we present an extension of our CACC system that allows vehicles to merge inside a platoon of vehicles at a junction, i.e., at a pre-defined location. Initially the merging vehicle and the platoon are outside each other’s communication range and are unaware of each other. Our merging algorithm is fully distributed and uses asynchronous multi-hop communication. Practical testing of our algorithm is planned for May 2011

Evaluating the Impact of Transmission Power on Selecting Tall Vehicles as Best Next Communication Hop

The relatively low height of antennas on communicating vehicles in Vehicular Ad Hoc Networks (VANETs) makes one hop and as well multi-hop Vehicle-to-Vehicle (V2V) communication susceptible to obstruction by other vehicles on the road. When the transmitter or receiver (or both) is a Tall vehi- cle, (i.e., truck), the V2V communication suffer less from these obstructions. The transmission power control is an important feature in the design of (multi- hop) VANET communication algorithms. However, the benefits of choosing a Tall vehicle when transmission power is varied are not yet extensively re- searched. Therefore, the main contribution of this paper is to evaluate the im- pact of transmission power control on the improved V2V communication capa- bilities of tall vehicles. Based on simulations, it is shown that significant bene- fits are observed when a Tall vehicle is selected rather than a Short vehicle as a next V2V communication hop to relay packets. Moreover, the simulation exper- iments show that as the transmission power is increasing, the rate of Tall vehi- cles that are selected as best next V2V communication hop is significantly growing

Constrained Geocast to Support Cooperative Adaptive Cruise Control (CACC) Merging

In this paper we introduce a new geocasting concept to target vehicles based on where they will be in the direct future, in stead of their current position. We refer to this concept as constrained geocast. This may be useful in situations where vehicles have interdependencies based on (future) maneuvers. We have developed a first version of such a protocol in the context of an automated merging application, and tested it using simulations. Results show that the protocol is able to meet the requirements of such applications. Compared to a\ud common geo-broadcast protocol this protocol becomes more reliable as road traffic densities increase, but in other aspects the performance is so far lacking. Based on our experiences with implementing the protocol however we see plenty of room for further improvement

Initiating pancreatic neuroendocrine tumour (pNET) screening in young MEN1 patients:results from the DutchMEN Study Group

Context: Nonfunctioning pancreatic neuroendocrine tumors (NF-pNETs) are highly prevalent and constitute an important cause of mortality in patients with multiple endocrine neoplasia type 1 (MEN1). Still, the optimal age to initiate screening for pNETs is under debate. Objective: The aim of this work is to assess the age of occurrence of clinically relevant NF-pNETs in young MEN1 patients. Methods: Pancreatic imaging data of MEN1 patients were retrieved from the DutchMEN Study Group database. Interval-censored survival methods were used to describe age-related penetrance, compare survival curves, and develop a parametric model for estimating the risk of having clinically relevant NF-pNET at various ages. The primary objective was to assess age at occurrence of clinically relevant NF-pNET (size ≥†20 mm or rapid growth); secondary objectives were the age at occurrence of NF-pNET of any size and pNET-associated metastasized disease. Results: Five of 350 patients developed clinically relevant NF-pNETs before age 18 years, 2 of whom subsequently developed lymph node metastases. No differences in clinically relevant NF-pNET-free survival were found for sex, time frame, and type of MEN1 diagnosis or genotype. The estimated ages (median, 95% CI) at a 1%, 2.5%, and 5% risk of having developed a clinically relevant tumor are 9.5 (6.5-12.7), 13.5 (10.2-16.9), and 17.8 years (14.3-21.4), respectively. Conclusion: Analyses from this population-based cohort indicate that start of surveillance for NF-pNETs with pancreatic imaging at age 13 to 14 years is justified. The psychological and medical burden of screening at a young age should be considered

Subclinical thyroid dysfunction and cognitive decline in old age

<p>Background: Subclinical thyroid dysfunction has been implicated as a risk factor for cognitive decline in old age, but results are inconsistent. We investigated the association between subclinical thyroid dysfunction and cognitive decline in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).</p> <p>Methods: Prospective longitudinal study of men and women aged 70–82 years with pre-existing vascular disease or more than one risk factor to develop this condition (N = 5,154). Participants taking antithyroid medications, thyroid hormone supplementation and/or amiodarone were excluded. Thyroid function was measured at baseline: subclinical hyper- and hypothyroidism were defined as thyroid stimulating hormones (TSH) <0.45 mU/L or >4.50 mU/L respectively, with normal levels of free thyroxine (FT4). Cognitive performance was tested at baseline and at four subsequent time points during a mean follow-up of 3 years, using five neuropsychological performance tests.</p> <p>Results: Subclinical hyperthyroidism and hypothyroidism were found in 65 and 161 participants, respectively. We found no consistent association of subclinical hyper- or hypothyroidism with altered cognitive performance compared to euthyroid participants on the individual cognitive tests. Similarly, there was no association with rate of cognitive decline during follow-up.</p> <p>Conclusion: We found no consistent evidence that subclinical hyper- or hypothyroidism contribute to cognitive impairment or decline in old age. Although our data are not in support of treatment of subclinical thyroid dysfunction to prevent cognitive dysfunction in later life, only large randomized controlled trials can provide definitive evidence.</p&gt